| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 83.272.266 $ | +12.881.729 $ | +33,2 % | 9 | 89.491.324 $ | +30.718.902 $ | +45,7 % | 10 | 42.840.106 $ | +14.674.814 $ | +58,9 % | 6 | ||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 14.649.657 $ | -2.481.221 $ | -14,5 % | 1 | 17.130.878 $ | +11.725.090 $ | +216,9 % | 1 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 10.720.735 $ | -133.040 $ | -1,2 % | 1 | 10.853.775 $ | +3.838.240 $ | +54,7 % | 1 | 7.015.535 $ | +3.183.950 $ | +83,1 % | 1 |
| CYTOKINETICS INC | CYTK | → 0 | Schwach | 10.790.653 $ | +2.864.102 $ | +36,1 % | 1 | 7.926.551 $ | +99.313 $ | +1,3 % | 1 | 7.827.238 $ | +4.000.644 $ | +104,5 % | 1 |
| Guardant Health, Inc. | GH | → 0 | Neutral | 7.642.324 $ | -2.385.985 $ | -23,8 % | 1 | 10.028.309 $ | +3.893.898 $ | +63,5 % | 1 | 6.134.411 $ | +1.025.020 $ | +20,1 % | 1 |
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 8.264.706 $ | -952.796 $ | -10,3 % | 1 | 9.217.502 $ | +646.435 $ | +7,5 % | 1 | 8.571.067 $ | +3.785.774 $ | +79,1 % | 1 |
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 8.627.567 $ | +5.204.024 $ | +152,0 % | 1 | ||||||||
| ALUMIS INC. | ALMS | → 0 | Neutral | 8.463.397 $ | +5.091.805 $ | +151,0 % | 1 | ||||||||
| ELI LILLY & Co | LLY | → 0 | Neutral | 6.449.427 $ | -1.988.960 $ | -23,6 % | 1 | 8.438.387 $ | +2.447.311 $ | +40,8 % | 1 | ||||
| FINANCIAL COUNSELORS INC | → 0 | 7.663.800 $ | +7.663.800 $ | 1 | |||||||||||
| Wave Life Sciences Ltd. | WVE | → 0 | Neutral | 7.165.296 $ | +7.165.296 $ | 1 | |||||||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Sehr schwach | 6.174.502 $ | -738.037 $ | -10,7 % | 1 | 6.912.539 $ | +196.624 $ | +2,9 % | 1 | ||||
| Travere Therapeutics, Inc. | TVTX | → 0 | Schwach | 6.256.964 $ | -122.352 $ | -1,9 % | 1 | 6.379.316 $ | +2.482.802 $ | +63,7 % | 1 | ||||
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 6.299.160 $ | +1.763.708 $ | +38,9 % | 1 | ||||||||
| 83.272.266 $ | +12.881.729 $ | +33,2 % | 9 | 89.491.324 $ | +30.718.902 $ | +45,7 % | 10 | 42.840.106 $ | +14.674.814 $ | +58,9 % | 6 | ||||